ArticleCancer chemotherapy and pharmacology2016

The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer.

Meiko Nishimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.